| neuron migration | GO:0001764 | 122 | 0.579 | |
| tertiary branching involved in mammary gland duct morphogenesis | GO:0060748 | 3 | 0.488 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.439 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.338 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.307 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.303 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.291 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.268 | |
| gland development | GO:0048732 | 330 | 0.265 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.248 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.238 | |
| cervix development | GO:0060067 | 2 | 0.235 | |
| adenylate cyclase inhibiting g protein coupled receptor signaling pathway | GO:0007193 | 20 | 0.235 | |
| regulation of cell motility | GO:2000145 | 236 | 0.223 | |
| placenta development | GO:0001890 | 140 | 0.220 | |
| mesoderm formation | GO:0001707 | 62 | 0.214 | |
| lung induction | GO:0060492 | 3 | 0.212 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.208 | |
| response to peptide | GO:1901652 | 136 | 0.207 | |
| endocrine system development | GO:0035270 | 98 | 0.207 | |
| oxygen homeostasis | GO:0032364 | 2 | 0.191 | |
| regulation of cell migration | GO:0030334 | 219 | 0.189 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.187 | |
| paraxial mesodermal cell fate commitment | GO:0048343 | 2 | 0.182 | |
| positive regulation of camp mediated signaling | GO:0043950 | 3 | 0.178 | |
| regulation of neuron death | GO:1901214 | 134 | 0.176 | |
| activation of adenylate cyclase activity | GO:0007190 | 4 | 0.176 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.175 | |
| regionalization | GO:0003002 | 337 | 0.171 | |
| forebrain cell migration | GO:0021885 | 58 | 0.164 | |
| follicle stimulating hormone secretion | GO:0046884 | 1 | 0.164 | |
| synaptic transmission | GO:0007268 | 329 | 0.161 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.159 | |
| diencephalon development | GO:0021536 | 63 | 0.158 | |
| lateral sprouting involved in mammary gland duct morphogenesis | GO:0060599 | 2 | 0.153 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.153 | |
| digestive tract development | GO:0048565 | 190 | 0.150 | |
| amide transport | GO:0042886 | 138 | 0.149 | |
| neuropeptide signaling pathway | GO:0007218 | 19 | 0.149 | |
| limbic system development | GO:0021761 | 72 | 0.144 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.144 | |
| neuron death | GO:0070997 | 154 | 0.144 | |
| glucose homeostasis | GO:0042593 | 128 | 0.141 | |
| positive regulation of transcription by glucose | GO:0046016 | 3 | 0.140 | |
| regulation of anagen | GO:0051884 | 1 | 0.140 | |
| mesoderm development | GO:0007498 | 100 | 0.137 | |
| somatostatin receptor signaling pathway | GO:0038169 | 2 | 0.136 | |
| female gonad development | GO:0008585 | 71 | 0.128 | Mouse |
| myeloid cell differentiation | GO:0030099 | 233 | 0.126 | Mouse |
| positive regulation of cell migration | GO:0030335 | 109 | 0.126 | |
| developmental maturation | GO:0021700 | 193 | 0.125 | |
| adult behavior | GO:0030534 | 135 | 0.125 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.124 | |
| angiogenesis | GO:0001525 | 201 | 0.123 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.121 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.121 | |
| subpallium neuron fate commitment | GO:0060163 | 2 | 0.121 | |
| spemann organizer formation at the anterior end of the primitive streak | GO:0060064 | 1 | 0.120 | |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.118 | |
| negative regulation of growth | GO:0045926 | 99 | 0.117 | |
| microtubule based process | GO:0007017 | 236 | 0.115 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.114 | |
| somatostatin signaling pathway | GO:0038170 | 2 | 0.109 | |
| axonogenesis | GO:0007409 | 274 | 0.107 | |
| outer medullary collecting duct development | GO:0072060 | 1 | 0.106 | |
| inner medullary collecting duct development | GO:0072061 | 2 | 0.105 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.104 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.104 | |
| response to peptide hormone | GO:0043434 | 127 | 0.101 | |
| wound healing | GO:0042060 | 157 | 0.097 | |
| connective tissue development | GO:0061448 | 179 | 0.096 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.095 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.094 | |
| regulation of female gonad development | GO:2000194 | 7 | 0.094 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.094 | |
| cardiac cell fate determination | GO:0060913 | 2 | 0.093 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.093 | |
| cardiac epithelial to mesenchymal transition | GO:0060317 | 18 | 0.092 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.092 | |
| positive regulation of inositol phosphate biosynthetic process | GO:0060732 | 2 | 0.090 | |
| oviduct development | GO:0060066 | 3 | 0.089 | |
| adenylate cyclase modulating g protein coupled receptor signaling pathway | GO:0007188 | 54 | 0.089 | |
| positive regulation of adenylate cyclase activity | GO:0045762 | 8 | 0.089 | |
| positive regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045899 | 2 | 0.085 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.085 | |
| ectoderm formation | GO:0001705 | 3 | 0.085 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.084 | |
| peptide secretion | GO:0002790 | 114 | 0.084 | |
| regulation of saliva secretion | GO:0046877 | 2 | 0.084 | |
| actin filament bundle assembly | GO:0051017 | 40 | 0.082 | |
| mesonephric duct formation | GO:0072181 | 2 | 0.082 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.081 | |
| multi organism behavior | GO:0051705 | 62 | 0.081 | |
| forebrain development | GO:0030900 | 302 | 0.081 | |
| nephric duct elongation | GO:0035849 | 1 | 0.081 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.081 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.080 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.080 | |
| organ growth | GO:0035265 | 117 | 0.078 | |
| operant conditioning | GO:0035106 | 2 | 0.078 | |
| skeletal system development | GO:0001501 | 356 | 0.078 | |
| extracellular structure organization | GO:0043062 | 148 | 0.078 | |
| amine metabolic process | GO:0009308 | 45 | 0.077 | |
| cell surface receptor signaling pathway involved in heart development | GO:0061311 | 15 | 0.077 | |
| regulation of secretion | GO:0051046 | 274 | 0.076 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.075 | Mouse |
| cell fate commitment | GO:0045165 | 210 | 0.075 | |
| ovulation cycle | GO:0042698 | 59 | 0.074 | Mouse |
| water homeostasis | GO:0030104 | 27 | 0.073 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.073 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.073 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.073 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.072 | |
| tissue homeostasis | GO:0001894 | 115 | 0.072 | Mouse |
| multi multicellular organism process | GO:0044706 | 109 | 0.071 | |
| tissue remodeling | GO:0048771 | 102 | 0.071 | Mouse |
| trabecular meshwork development | GO:0002930 | 2 | 0.070 | |
| germ cell development | GO:0007281 | 185 | 0.070 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.069 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.068 | |
| positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | GO:0072108 | 3 | 0.068 | |
| adenylate cyclase activating g protein coupled receptor signaling pathway | GO:0007189 | 30 | 0.067 | |
| lipid transport | GO:0006869 | 98 | 0.066 | |
| dopaminergic neuron differentiation | GO:0071542 | 14 | 0.066 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.066 | |
| pancreatic pp cell fate commitment | GO:0003329 | 2 | 0.066 | |
| neuron fate specification | GO:0048665 | 30 | 0.065 | |
| glial cell differentiation | GO:0010001 | 131 | 0.065 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.064 | |
| positive regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway | GO:0010579 | 3 | 0.064 | |
| rhythmic process | GO:0048511 | 174 | 0.064 | Mouse |
| neuroblast proliferation | GO:0007405 | 49 | 0.064 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.063 | |
| planar cell polarity pathway involved in pericardium morphogenesis | GO:0061354 | 2 | 0.063 | |
| epithelial cell development | GO:0002064 | 159 | 0.063 | |
| histamine induced gastric acid secretion | GO:0001697 | 1 | 0.062 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.062 | |
| embryonic placenta development | GO:0001892 | 98 | 0.061 | |
| general adaptation syndrome | GO:0051866 | 2 | 0.061 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.060 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.060 | Mouse |
| spemann organizer formation | GO:0060061 | 2 | 0.059 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.059 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.059 | |
| midbrain hindbrain boundary maturation | GO:0021732 | 1 | 0.058 | |
| carbon catabolite activation of transcription from rna polymerase ii promoter | GO:0000436 | 4 | 0.058 | |
| carbon catabolite repression of transcription from rna polymerase ii promoter | GO:0000437 | 1 | 0.058 | |
| camera type eye development | GO:0043010 | 266 | 0.057 | |
| bone remodeling | GO:0046849 | 53 | 0.057 | Mouse |
| spinal cord oligodendrocyte cell differentiation | GO:0021529 | 3 | 0.056 | |
| sensory perception | GO:0007600 | 245 | 0.056 | |
| multicellular organism growth | GO:0035264 | 161 | 0.056 | |
| spinal cord oligodendrocyte cell fate specification | GO:0021530 | 3 | 0.055 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.055 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.054 | |
| mesenchymal to epithelial transition | GO:0060231 | 12 | 0.054 | |
| epithelial cell morphogenesis | GO:0003382 | 41 | 0.054 | |
| paramesonephric duct development | GO:0061205 | 3 | 0.054 | |
| muscle tissue development | GO:0060537 | 308 | 0.054 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.054 | |
| gastrulation | GO:0007369 | 116 | 0.054 | |
| cerebellum formation | GO:0021588 | 1 | 0.054 | |
| establishment of organ orientation | GO:0048561 | 1 | 0.053 | |
| peptide transport | GO:0015833 | 133 | 0.053 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.053 | |
| nephric duct formation | GO:0072179 | 4 | 0.052 | |
| chromatin organization | GO:0006325 | 206 | 0.052 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.052 | |
| odontogenesis | GO:0042476 | 78 | 0.052 | |
| gastrin induced gastric acid secretion | GO:0001698 | 1 | 0.052 | |
| hormone secretion | GO:0046879 | 128 | 0.052 | |
| male gamete generation | GO:0048232 | 285 | 0.052 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.052 | Mouse |
| ventral spinal cord development | GO:0021517 | 48 | 0.052 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.051 | |
| cell differentiation in spinal cord | GO:0021515 | 53 | 0.051 | |
| spinal cord development | GO:0021510 | 81 | 0.050 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.050 | |
| midbrain hindbrain boundary maturation during brain development | GO:0022004 | 1 | 0.050 | |
| planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:0061350 | 2 | 0.050 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.050 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.050 | |
| adrenal gland development | GO:0030325 | 18 | 0.049 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.049 | |
| negative regulation of cellular response to growth factor stimulus | GO:0090288 | 46 | 0.049 | |
| adenylate cyclase inhibiting serotonin receptor signaling pathway | GO:0007198 | 1 | 0.048 | |
| regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000079 | 1 | 0.048 | |
| sensory system development | GO:0048880 | 3 | 0.047 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.047 | Mouse |
| regulation of cell cycle | GO:0051726 | 281 | 0.047 | |
| wnt signaling pathway involved in forebrain neuroblast division | GO:0021874 | 2 | 0.047 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.047 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.046 | Mouse |
| positive regulation of epithelial cell differentiation involved in kidney development | GO:2000698 | 2 | 0.046 | |
| cellular response to ethanol | GO:0071361 | 3 | 0.045 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.045 | |
| hormone metabolic process | GO:0042445 | 86 | 0.045 | |
| positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000081 | 1 | 0.045 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.045 | |
| regulation of synaptic plasticity | GO:0048167 | 87 | 0.045 | |
| developmental induction | GO:0031128 | 34 | 0.045 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.044 | |
| heart morphogenesis | GO:0003007 | 178 | 0.044 | |
| horizontal cell localization | GO:0035852 | 1 | 0.044 | |
| negative regulation of testosterone biosynthetic process | GO:2000225 | 1 | 0.044 | |
| somatotropin secreting cell development | GO:0060133 | 2 | 0.043 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.043 | Mouse |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.043 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.043 | |
| spermatogenesis | GO:0007283 | 284 | 0.043 | |
| positive regulation of kidney development | GO:0090184 | 28 | 0.042 | |
| motor neuron migration | GO:0097475 | 4 | 0.042 | |
| opioid receptor signaling pathway | GO:0038003 | 5 | 0.042 | |
| neuroblast differentiation | GO:0014016 | 2 | 0.042 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.042 | |
| regulation of mesenchymal cell apoptotic process involved in metanephros development | GO:1900211 | 4 | 0.041 | |
| pericardium development | GO:0060039 | 16 | 0.041 | |
| kidney rudiment formation | GO:0072003 | 3 | 0.041 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.041 | |
| positive regulation of cell cell adhesion mediated by cadherin | GO:2000049 | 2 | 0.041 | |
| regulation of organ formation | GO:0003156 | 34 | 0.041 | |
| lymphocyte apoptotic process | GO:0070227 | 54 | 0.041 | |
| segmentation | GO:0035282 | 93 | 0.040 | |
| specification of organ identity | GO:0010092 | 30 | 0.040 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.040 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.040 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.040 | |
| membrane organization | GO:0061024 | 245 | 0.040 | |
| coagulation | GO:0050817 | 78 | 0.040 | |
| mitral valve development | GO:0003174 | 4 | 0.040 | |
| organ induction | GO:0001759 | 21 | 0.040 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.040 | |
| renal sodium excretion | GO:0035812 | 3 | 0.040 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.039 | |
| embryonic viscerocranium morphogenesis | GO:0048703 | 8 | 0.039 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.039 | |
| female genitalia development | GO:0030540 | 14 | 0.039 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.038 | |
| uterine epithelium development | GO:0035847 | 1 | 0.038 | |
| gtp metabolic process | GO:0046039 | 144 | 0.038 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.038 | |
| protein ubiquitination | GO:0016567 | 171 | 0.037 | |
| cerebral cortex gabaergic interneuron differentiation | GO:0021892 | 9 | 0.037 | |
| interleukin 8 production | GO:0032637 | 4 | 0.037 | |
| cartilage development | GO:0051216 | 140 | 0.037 | |
| apoptotic process involved in development | GO:1902742 | 28 | 0.036 | |
| cerebral cortex development | GO:0021987 | 86 | 0.036 | |
| long term synaptic potentiation | GO:0060291 | 25 | 0.036 | |
| maintenance of protein location in nucleus | GO:0051457 | 2 | 0.036 | |
| oviduct epithelium development | GO:0035846 | 1 | 0.036 | |
| planar cell polarity pathway involved in ventricular septum morphogenesis | GO:0061348 | 2 | 0.036 | |
| testosterone biosynthetic process | GO:0061370 | 2 | 0.035 | |
| epithelial tube formation | GO:0072175 | 130 | 0.035 | |
| astrocyte fate commitment | GO:0060018 | 4 | 0.035 | |
| peyer s patch morphogenesis | GO:0061146 | 3 | 0.035 | |
| learning or memory | GO:0007611 | 148 | 0.035 | |
| female sex differentiation | GO:0046660 | 84 | 0.035 | Mouse |
| endocrine hormone secretion | GO:0060986 | 15 | 0.035 | |
| stem cell proliferation | GO:0072089 | 117 | 0.035 | |
| embryonic hemopoiesis | GO:0035162 | 23 | 0.035 | |
| rna polymerase ii transcriptional preinitiation complex assembly | GO:0051123 | 3 | 0.034 | |
| vagina development | GO:0060068 | 11 | 0.034 | |
| positive regulation of mesenchymal cell proliferation | GO:0002053 | 33 | 0.034 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.034 | |
| regulation of protein modification by small protein conjugation or removal | GO:1903320 | 57 | 0.034 | |
| oocyte development | GO:0048599 | 33 | 0.034 | |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 56 | 0.034 | |
| pituitary gland development | GO:0021983 | 38 | 0.034 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.034 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.034 | Mouse |
| neuron fate determination | GO:0048664 | 9 | 0.033 | |
| palate development | GO:0060021 | 76 | 0.033 | |
| ovarian follicle development | GO:0001541 | 40 | 0.033 | Mouse |
| oxidation reduction process | GO:0055114 | 342 | 0.033 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.033 | |
| lung field specification | GO:0060424 | 3 | 0.032 | |
| telencephalon development | GO:0021537 | 186 | 0.032 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.032 | Mouse |
| regulation of t cell differentiation | GO:0045580 | 83 | 0.032 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.032 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.032 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.031 | |
| central nervous system neuron development | GO:0021954 | 67 | 0.031 | |
| chromatin modification | GO:0016568 | 187 | 0.031 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.031 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.031 | |
| regulation of adenylate cyclase activity | GO:0045761 | 10 | 0.031 | |
| metanephric tubule development | GO:0072170 | 18 | 0.031 | |
| renal inner medulla development | GO:0072053 | 3 | 0.031 | |
| sensory perception of sound | GO:0007605 | 97 | 0.031 | |
| ubiquitin dependent smad protein catabolic process | GO:0030579 | 2 | 0.031 | |
| cerebellum development | GO:0021549 | 77 | 0.031 | |
| canonical wnt signaling pathway involved in regulation of cell proliferation | GO:0044340 | 3 | 0.031 | |
| urinary tract smooth muscle contraction | GO:0014848 | 6 | 0.030 | |
| regulation of mesonephros development | GO:0061217 | 24 | 0.030 | |
| b cell activation | GO:0042113 | 161 | 0.030 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.030 | |
| embryonic heart tube morphogenesis | GO:0003143 | 51 | 0.030 | |
| organelle localization | GO:0051640 | 179 | 0.030 | |
| visceral serous pericardium development | GO:0061032 | 2 | 0.030 | |
| positive regulation of growth | GO:0045927 | 104 | 0.030 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.030 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.029 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.029 | |
| sodium ion transport | GO:0006814 | 73 | 0.029 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.029 | |
| positive regulation of intracellular steroid hormone receptor signaling pathway | GO:0033145 | 4 | 0.029 | |
| establishment or maintenance of polarity of embryonic epithelium | GO:0016332 | 1 | 0.029 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.029 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 38 | 0.029 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.029 | |
| hair follicle development | GO:0001942 | 85 | 0.028 | |
| establishment of planar polarity involved in nephron morphogenesis | GO:0072046 | 1 | 0.028 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.028 | |
| regulation of cardioblast differentiation | GO:0051890 | 3 | 0.028 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.028 | |
| negative regulation of female gonad development | GO:2000195 | 3 | 0.028 | |
| g protein coupled receptor internalization | GO:0002031 | 3 | 0.028 | |
| synapse organization | GO:0050808 | 125 | 0.028 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.028 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.028 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.028 | |
| planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:0061349 | 2 | 0.027 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.027 | |
| metanephros morphogenesis | GO:0003338 | 24 | 0.027 | |
| negative regulation of adenylate cyclase activity | GO:0007194 | 1 | 0.027 | |
| negative regulation of cell morphogenesis involved in differentiation | GO:0010771 | 48 | 0.027 | |
| positive regulation of transforming growth factor beta2 production | GO:0032915 | 2 | 0.027 | |
| tendon cell differentiation | GO:0035990 | 4 | 0.027 | |
| steroid metabolic process | GO:0008202 | 119 | 0.027 | |
| positive regulation of renal sodium excretion | GO:0035815 | 2 | 0.027 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.027 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.027 | |
| renal vesicle induction | GO:0072034 | 3 | 0.027 | |
| positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway | GO:0051482 | 4 | 0.026 | |
| positive regulation of actin filament bundle assembly | GO:0032233 | 11 | 0.026 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.026 | |
| protein catabolic process | GO:0030163 | 221 | 0.026 | |
| dendrite development | GO:0016358 | 115 | 0.026 | |
| forebrain neuron development | GO:0021884 | 30 | 0.026 | |
| digestive system development | GO:0055123 | 200 | 0.026 | |
| renal outer medulla development | GO:0072054 | 2 | 0.026 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.026 | |
| mesonephric tubule formation | GO:0072172 | 11 | 0.026 | |
| mesodermal cell differentiation | GO:0048333 | 22 | 0.026 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.025 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.025 | |
| regulation of renal sodium excretion | GO:0035813 | 3 | 0.025 | |
| uterus morphogenesis | GO:0061038 | 2 | 0.025 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.025 | |
| transmembrane transport | GO:0055085 | 412 | 0.025 | |
| endocytosis | GO:0006897 | 168 | 0.025 | |
| endomembrane system organization | GO:0010256 | 147 | 0.025 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.025 | |
| positive regulation of stress fiber assembly | GO:0051496 | 9 | 0.025 | |
| regulation of lipid transport | GO:0032368 | 36 | 0.025 | |
| regulation of reproductive process | GO:2000241 | 66 | 0.025 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.025 | |
| regulation of endothelial cell migration | GO:0010594 | 22 | 0.025 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.025 | |
| negative regulation of transforming growth factor beta receptor signaling pathway | GO:0030512 | 26 | 0.024 | |
| post anal tail morphogenesis | GO:0036342 | 23 | 0.024 | |
| positive regulation of glycolytic process | GO:0045821 | 4 | 0.024 | |
| ossification | GO:0001503 | 216 | 0.024 | |
| hydrogen transport | GO:0006818 | 35 | 0.024 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.024 | |
| tube closure | GO:0060606 | 91 | 0.024 | |
| cop9 signalosome assembly | GO:0010387 | 2 | 0.024 | |
| apoptotic process involved in morphogenesis | GO:0060561 | 25 | 0.024 | |
| response to growth factor | GO:0070848 | 198 | 0.024 | |
| regulation of lateral mesodermal cell fate specification | GO:0048378 | 2 | 0.023 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.023 | |
| regulation of cell growth | GO:0001558 | 91 | 0.023 | |
| regulation of ossification | GO:0030278 | 112 | 0.023 | |
| endoderm development | GO:0007492 | 45 | 0.023 | |
| positive regulation of anterior head development | GO:2000744 | 2 | 0.023 | |
| mesonephros development | GO:0001823 | 97 | 0.023 | |
| positive regulation of interleukin 8 production | GO:0032757 | 2 | 0.023 | |
| behavioral response to ethanol | GO:0048149 | 8 | 0.023 | |
| cell migration involved in heart development | GO:0060973 | 8 | 0.023 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.023 | |
| epithelial mesenchymal signaling involved in prostate gland development | GO:0060738 | 2 | 0.023 | |
| regulation of binding | GO:0051098 | 111 | 0.023 | |
| neural tube closure | GO:0001843 | 90 | 0.023 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.022 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.022 | |
| renal tubule development | GO:0061326 | 87 | 0.022 | |
| associative learning | GO:0008306 | 61 | 0.022 | |
| regulation of retina development in camera type eye | GO:1902866 | 3 | 0.022 | |
| negative regulation of androgen biosynthetic process | GO:2000180 | 1 | 0.022 | |
| regulation of camp metabolic process | GO:0030814 | 30 | 0.022 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.022 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.022 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.022 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.022 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.022 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.022 | |
| somitogenesis | GO:0001756 | 69 | 0.021 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.021 | |
| trachea cartilage morphogenesis | GO:0060535 | 4 | 0.021 | |
| pancreatic a cell fate commitment | GO:0003326 | 2 | 0.021 | |
| branching involved in mammary gland duct morphogenesis | GO:0060444 | 27 | 0.021 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.021 | |
| interferon gamma production | GO:0032609 | 67 | 0.021 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.021 | |
| synaptic transmission glutamatergic | GO:0035249 | 36 | 0.021 | |
| cation homeostasis | GO:0055080 | 212 | 0.021 | |
| rhombomere formation | GO:0021594 | 1 | 0.021 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.021 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.021 | |
| epithelial cell migration | GO:0010631 | 63 | 0.021 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.021 | |
| negative regulation of type b pancreatic cell apoptotic process | GO:2000675 | 3 | 0.021 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.021 | |
| negative regulation of apoptotic process involved in outflow tract morphogenesis | GO:1902257 | 2 | 0.021 | |
| cell maturation | GO:0048469 | 127 | 0.021 | |
| auditory receptor cell fate specification | GO:0042667 | 1 | 0.020 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.020 | |
| auditory receptor cell differentiation | GO:0042491 | 37 | 0.020 | |
| skin development | GO:0043588 | 220 | 0.020 | |
| lipid localization | GO:0010876 | 126 | 0.020 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.020 | |
| renal vesicle development | GO:0072087 | 17 | 0.020 | |
| spermatid development | GO:0007286 | 108 | 0.020 | |
| negative regulation of neuron projection development | GO:0010977 | 50 | 0.020 | |
| maintenance of cell number | GO:0098727 | 3 | 0.020 | |
| regulation of neural retina development | GO:0061074 | 3 | 0.020 | |
| regulation of generation of precursor metabolites and energy | GO:0043467 | 38 | 0.020 | |
| adenohypophysis development | GO:0021984 | 14 | 0.020 | |
| response to ethanol | GO:0045471 | 18 | 0.020 | |
| postganglionic parasympathetic nervous system development | GO:0021784 | 2 | 0.020 | |
| substrate independent telencephalic tangential interneuron migration | GO:0021843 | 8 | 0.020 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.020 | |
| biological phase | GO:0044848 | 20 | 0.020 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.020 | |
| response to acid chemical | GO:0001101 | 111 | 0.019 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.019 | |
| regulation of cell cell adhesion mediated by cadherin | GO:2000047 | 2 | 0.019 | |
| general adaptation syndrome behavioral process | GO:0051867 | 1 | 0.019 | |
| positive regulation of cardioblast differentiation | GO:0051891 | 3 | 0.019 | |
| axis elongation involved in somitogenesis | GO:0090245 | 4 | 0.019 | |
| cell fate specification | GO:0001708 | 72 | 0.019 | |
| g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger | GO:0007187 | 55 | 0.019 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.019 | |
| inner ear receptor cell differentiation | GO:0060113 | 61 | 0.019 | |
| serotonin receptor signaling pathway | GO:0007210 | 8 | 0.019 | |
| epithelial cell fate commitment | GO:0072148 | 13 | 0.019 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.019 | |
| regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | GO:0003339 | 5 | 0.019 | |
| positive regulation of the force of heart contraction by chemical signal | GO:0003099 | 3 | 0.019 | |
| negative regulation of feeding behavior | GO:2000252 | 1 | 0.019 | |
| regulation of branching involved in ureteric bud morphogenesis | GO:0090189 | 22 | 0.019 | |
| cerebral cortex neuron differentiation | GO:0021895 | 19 | 0.019 | |
| canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation | GO:0044343 | 1 | 0.019 | |
| ventral spinal cord interneuron fate commitment | GO:0060579 | 14 | 0.019 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.019 | |
| regulation of lymphocyte apoptotic process | GO:0070228 | 41 | 0.019 | |
| mesonephric duct morphogenesis | GO:0072180 | 4 | 0.019 | |
| cerebral cortex gabaergic interneuron migration | GO:0021853 | 6 | 0.019 | |
| regulation of mesenchymal cell proliferation | GO:0010464 | 37 | 0.018 | |
| positive regulation of camp metabolic process | GO:0030816 | 19 | 0.018 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.018 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.018 | |
| thymus development | GO:0048538 | 41 | 0.018 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.018 | |
| uterus development | GO:0060065 | 16 | 0.018 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.018 | |
| visceral motor neuron differentiation | GO:0021524 | 3 | 0.018 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.018 | |
| glomerular mesangial cell development | GO:0072144 | 3 | 0.018 | |
| circulatory system process | GO:0003013 | 197 | 0.018 | |
| positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process | GO:2000763 | 1 | 0.018 | |
| developmental programmed cell death | GO:0010623 | 41 | 0.018 | |
| positive regulation of mesonephros development | GO:0061213 | 20 | 0.018 | |
| protein localization to vacuole | GO:0072665 | 4 | 0.018 | |
| regulation of ion transport | GO:0043269 | 215 | 0.018 | |
| osteoclast differentiation | GO:0030316 | 62 | 0.018 | Mouse |
| negative regulation of reproductive process | GO:2000242 | 31 | 0.018 | |
| cell junction assembly | GO:0034329 | 52 | 0.018 | |
| nephron development | GO:0072006 | 109 | 0.018 | |
| granulocyte colony stimulating factor production | GO:0071611 | 1 | 0.018 | |
| regulation of insulin secretion involved in cellular response to glucose stimulus | GO:0061178 | 31 | 0.018 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.018 | |
